Hormesis and synergy: Pathways and mechanisms of quercetin in cancer prevention and management

Nutrition Reviews

Volumn 68, Issue 7, 2010, Pages 418-428

  Vargas, Ashley J ^a   Burd, Randy ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Estrogen receptor; HSPs; P53; Quercetin; ROS

Indexed keywords

8 HYDROXYGUANINE; AGLYCONE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CASEIN KINASE II; CASPASE 3; CASPASE 8; CASPASE 9; CELL DNA; CHAPERONE; CYTOCHROME C; DRUG METABOLITE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; GLUTATHIONE; GLYCOSIDASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; ISORHAMMETIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; QUERCETIN; SOMATOMEDIN BINDING PROTEIN 2; SURVIVIN; TAMARIXETIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIOXIDANT; OXIDIZING AGENT;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER PREVENTION; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CHELATION; CHEMOPROPHYLAXIS; COLON ADENOCARCINOMA; DIETARY INTAKE; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG ABSORPTION; DRUG ACTIVITY; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG METABOLISM; ELECTRON; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GLIOMA CELL; HELA CELL; HERB; HORMESIS; HUMAN; INHIBITION KINETICS; MITOCHONDRION; NEOPLASM; NONHUMAN; NUT; OXIDATIVE STRESS; PROTEIN EXPRESSION; RECTUM CARCINOMA; REVIEW; SIGNAL TRANSDUCTION; TEA; VEGETABLE; ANIMAL; DIET SUPPLEMENTATION; DIET THERAPY; DOSE RESPONSE; NEOPLASMS; OSMOLARITY;

ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEOPLASMS; OSMOLAR CONCENTRATION; OXIDANTS; QUERCETIN;

EID: 77956634425     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2010.00301.x     Document Type: Review

References (48)

1. Watjen W, Michels G, Steffan B, et al. Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis. J Nutr. 2005;135:525-531.
2. Awad HM, Boersma MG, Vervoort J, Rietjens IM. Peroxidasecatalyzed formation of quercetin quinone methideglutathione adducts. Arch Biochem Biophys. 2000;378: 224-233.
3. Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med. 1999;26:107-116.
4. Egert S, Wolffram S, Bosy-Westphal A, et al. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr. 2008;138:1615-1621.
5. Harwood M, Nielewska-Nikiel B, Borzelleca JF, et al. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/ carcinogenic properties. Food Chem Toxicol. 2007;45:2179-2205.
6. Alia M, Mateos R, Ramos S, et al. Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line HepG2. Eur J Nutr. 2006;45:19-28.
7. Walle T, Browning AM, Steed LL, Reed SG,Walle UK. Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr. 2005;135:48-52.
8. Murota K, Terao J. Antioxidative flavonoid quercetin: Implication of its intestinal absorption and metabolism. Arch Biochem Biophys. 2003;417:12-17.
9. Day AJ, Gee JM, DuPont MS, Johnson IT, Williamson G. Absorption of quercetin-3-glucoside and quercetin-4'- glucoside in the rat small intestine: The role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol. 2003;65:1199-1206.
10. Bieger J, Cermak R, Blank R, et al. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr. 2008;138:1417-1420.
11. Spencer JP, Kuhnle GG,Williams RJ, Rice-Evans C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J. 2003;372:173-181.
12. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81(Suppl):S230-S242.
13. Silberberg M, Morand C, Manach C, Scalbert A, Remesy C. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism. Life Sci. 2005;77:3156-3167.
14. Ferry DR, Smith A, Malkhandi J, et al. Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996;2:659-668.
15. Min K, Ebeler SE. Quercetin inhibits hydrogen peroxideinduced DNA damage and enhances DNA repair in Caco-2 cells. Food Chem Toxicol. 2009;47:2716-2722.
16. Boots AW, Kubben N, Haenen GR, Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: Implication for quercetin supplementation. Biochem Biophys Res Commun. 2003;308:560-565.
17. Kim GN, Jang HD. Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells. Ann N Y Acad Sci. 2009;1171:530-537.
18. Santos MR, Rodriguez-Gomez MJ, Justino GC, et al. Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in rats. Br J Pharmacol. 2008;153:1750-1761.
19. Murota K, Hotta A, Ido H, et al. Antioxidant capacity of albumin-bound quercetin metabolites after onion consumption in humans. J Med Invest. 2007;54:370-374.
20. Justino GC, Santos MR, Canario S, et al. Plasma quercetin metabolites: Structure-antioxidant activity relationships. Arch Biochem Biophys. 2004;432:109-121.
21. Thangasamy T, Sittadjody S, Lanza-Jacoby S, et al. Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase. Nutr Cancer. 2007;59:258-268.
22. Thangasamy T, Sittadjody S, Limesand KH, Burd R. Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbazine. Cell Oncol. 2008;30:371-387.
23. Hao Z, Duncan GS, Chang CC, et al. Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell. 2005;121:579-591.
24. Tan J, Wang B, Zhu L. Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin. Chem Biodivers. 2009;6:1101-1110.
25. Zhang Q, Zhao XH, Wang ZJ. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line OE33 by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol. 2008;46:2042-2053.
26. Zhang Q, Zhao XH, Wang ZJ. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line KYSE-510 by induction of G2/M arrest and apoptosis. Toxicol In Vitro. 2009;23:797-807.
27. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med. 2006;12:440-450.
28. Chien SY,Wu YC, Chung JG, et al. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum Exp Toxicol. 2009;28:493-503.
29. Porte S, Valencia E, Yakovtseva EA, et al. Three-dimensional structure and enzymatic function of proapoptotic human p53-inducible quinone oxidoreductase PIG3. J Biol Chem. 2009;284:17194-17205.
30. Wajant H. The Fas signaling pathway: More than a paradigm. Science. 2002;296:1635-1636.
31. Siegelin MD, Reuss DE, Habel A, Rami A, von Deimling A. Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells. Neuro Oncol. 2009;11:122-131.
32. Deng Y, Lin Y, Wu X. TRAIL-induced apoptosis requires Baxdependent mitochondrial release of Smac/DIABLO. Genes Dev. 2002;16:33-45.
33. Galluzzo P, Martini C, Bulzomi P, et al. Quercetin-induced apoptotic cascade in cancer cells: Antioxidant versus estrogen receptor alpha-dependent mechanisms. Mol Nutr Food Res. 2009;53:699-708.
34. Porras A, Zuluaga S, Black E, et al. P38 alpha mitogenactivated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell. 2004;15:922-933.
35. Sotoca AM, Ratman D, van der SP, et al. Phytoestrogenmediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol. 2008;112:171-178.
36. Subramanian M, Shaha C. Estrogen modulates human macrophage apoptosis via differential signaling through estrogen receptor-alpha and beta. J Cell Mol Med. 2009;13: 2317-2329.
37. Williams C, Edvardsson K, Lewandowski SA, Strom A, Gustafsson JA. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene. 2008;27:1019-1032.
38. Aalinkeel R, Bindukumar B, Reynolds JL, et al. The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate. 2008;68:1773-1789.
39. Wang RE, Kao JL, Hilliard CA, et al. Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. J Med Chem. 2009;52:1912-1921.
40. Li M, Wang J, Jin J, et al. Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70. J Cell Mol Med. 2008;13:4540-4550.
41. Taiyab A, Sreedhar AS, Rao C. Hsp90 inhibitors, GA and 17AAG, lead to ER stress-induced apoptosis in rat histiocytoma. Biochem Pharmacol. 2009;78:142-152.
42. Lee E, Nichols P, Spicer D, et al. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res. 2006;66:7849-7853.
43. Ito T, Warnken SP, May WS. Protein synthesis inhibition by flavonoids: Roles of eukaryotic initiation factor 2alpha kinases. Biochem Biophys Res Commun. 1999;265:589-594.
44. Ma ZS, Huynh TH, Ng CP, et al. Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation. Int J Oncol. 2004;24:1297-1304.
45. Moon YJ, Shin BS, An G, Morris ME. Biochanin A inhibits breast cancer tumor growth in a murine xenograft model. Pharm Res. 2008;25:2158-2163.
46. Miyamoto S, Yasui Y, Ohigashi H, Tanaka T, Murakami A. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. Chem Biol Interact. 2009;183:276-283.
47. Wachsberger PR, Burd R, Marero N, et al. Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. Clin Cancer Res. 2005;11:835-842.
48. Wang L, Lee IM, Zhang SM, et al. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr. 2009;89:905-912.